AMY BAILEY: Open Payments
NPI 1003161373 · AMORY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 19 payments from 9 companies in 2025. Trend: 2023 $652 · 2024 $434 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $136 |
| Abbott Laboratories | 5 | $109 |
| Novo Nordisk Inc | 3 | $68 |
| ABBVIE INC. | 1 | $29 |
| PFIZER INC. | 1 | $25 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Boston Scientific Corporation | 1 | $23 |
| Amgen Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 2 | $9 |
Products named: FREESTYLE LIBRE 3, AIRSUPRA, Ozempic, FARXIGA, VRAYLAR, ACCRUFER, WATCHMAN FLX, OTEZLA.
Industry payments across MS — which companies pay providers there.
